CEBPA and acute myeloid leukemia: Conversely, downregulation of the miR‐181 family members were identified in a specific subset of cytogenetically normal AML patients and moreover, the upregulation of miR‐181 family was associated with better outcomes in C/EBPα ‐mutated AML, where the mutated C/EBPα directly targets miR‐181 [67].